Skip to main content
Clinical Trials/CTRI/2025/07/091842
CTRI/2025/07/091842Not yet recruitingPhase 2

A Clinical Study to Evaluate the Efficacy Of Nagarpippalyadi Yog in the Management of Kashtartava Primary Dysmenorrhea

Dr REENA1 site in 1 country192 target enrollmentStarted: August 14, 2025Last updated:

Trial Snapshot

Phase
Phase 2
Status
Not yet recruiting
Sponsor
Enrollment
192
Locations
1
Primary Endpoint
Reduction in pain intensity VAS scale

Study Overview

Brief Summary

All gynecological problems are outlined under the broad name Yonivyapada in Ayurvedic epics. Though the disease "Kashtartava" is not regarded as a distinct entity. In the literature it is a symptom of many Yonivyapadas particularly Udavarta  Vatala Sannipatika etc. Kashtartava is a condition that can be seen from 14 to 50 years old. Dysmenorrhea prevalence rates vary by age and region. It affects between 15.8 percent and 89.5 percent of menstruating women worldwide with 2 percent to 29.9 percent reporting severe pain. According to studies in India primary dysmenorrhea rates range from 50 percent to 87.8 percent. It is a Tridoshaja Vyadhi with Vata predominance in the female genital tract pathologically. This research study seeks to evaluate the efficacy of Nagarpippalyadi Yoga in managing Kashtartava primary dysmenorrhea offering a natural safe and effective alternative to conventional treatments. The study is significant in both validating traditional Ayurvedic formulations and providing a solution to a condition that affects millions of women globally. By contributing to the scientific validation of Ayurvedic therapies this research could have a lasting impact on integrative medicine and women’s health management. This justification emphasizes the importance relevance and potential benefits of conducting this clinical study while aligning the traditional wisdom of Ayurveda with modern scientific inquiry.

Study Design

Study Type
Interventional
Allocation
Coin toss, Lottery, toss of dice, shuffling cards etc
Masking
None

Eligibility Criteria

Ages
12.00 Year(s) to 40.00 Year(s) (—)
Sex
Female

Inclusion Criteria

  • patients having signs and symptoms of Kastaratava ex painful mensturation Nausea Vomitting Breast tenderness Headache and history of regular Menstrual cycle.

Exclusion Criteria

  • Irregular periods Trauma Patients Anatomical Anomaly Systemic Reproductive tract pathology.

Outcomes

Primary Outcomes

Reduction in pain intensity VAS scale

Time Frame: 3 months

Secondary Outcomes

  • improvement in overall quality of life(3 months)

Investigators

Sponsor
Dr REENA
Sponsor Class
Other [self sponsored]
Responsible Party
Principal Investigator
Principal Investigator

Dr Reena

Shree Guru Govind Tricentenary University Chandu Budhera Gurugram

Study Sites (1)

Loading locations...

Similar Trials